Meeting
2022 ASCO Annual Meeting
Gender disparity in authorship of clinical trials leading to cancer drug approvals between 2008 and 2018: The glass ceiling of academic oncology.
Authors
Lynne O. Chapman
Baylor College of Medicine, Houston, TX
Lynne O. Chapman , Jonathan M. Loree , Seerat Anand , Shehara Ramyalini Mendis , Lorna H McNeill , Kanwal Pratap Singh Raghav , Gauri Rajani Varadhachary
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Professional Development and Education Advances
Track
Medical Education and Professional Development
Sub Track
Workplace Disparities/Issues
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 11048)
DOI
10.1200/JCO.2022.40.16_suppl.11048
Abstract #
11048
Poster Bd #
239
Abstract Disclosures
Similar Posters
Poster
2020 ASCO Virtual Scientific Program
Gender-based disparities in clinical trials supporting FDA approval of oncology drugs.
First Author: Marjorie Zettler
Poster
2020 Gastrointestinal Cancers Symposium
Female representation in clinical trials leading to FDA cancer drug approvals for gastrointestinal (GI) cancers between 2008 to 2018.
First Author: Shehara Ramyalini Mendis
Poster
2011 ASCO Annual Meeting
Gender, age, and ethnic representation in non-small cell lung cancer (NSCLC) U.S. registration trials: FDA review.
First Author: S. M. Malik
Poster
2023 ASCO Quality Care Symposium
Gender equity education in oncology: A survey study of hematology-oncology fellowship program directors.
First Author: Christina Hum